1
|
Ramezani G, Stiharu I, van de Ven TGM, Nerguizian V. Advancements in Hybrid Cellulose-Based Films: Innovations and Applications in 2D Nano-Delivery Systems. J Funct Biomater 2024; 15:93. [PMID: 38667550 PMCID: PMC11051498 DOI: 10.3390/jfb15040093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Revised: 03/29/2024] [Accepted: 03/31/2024] [Indexed: 04/28/2024] Open
Abstract
This review paper delves into the realm of hybrid cellulose-based materials and their applications in 2D nano-delivery systems. Cellulose, recognized for its biocompatibility, versatility, and renewability, serves as the core matrix for these nanomaterials. The paper offers a comprehensive overview of the latest advancements in the creation, analysis, and application of these materials, emphasizing their significance in nanotechnology and biomedical domains. It further illuminates the integration of nanomaterials and advanced synthesis techniques that have significantly improved the mechanical, chemical, and biological properties of hybrid cellulose-based materials.
Collapse
Affiliation(s)
- Ghazaleh Ramezani
- Department of Mechanical, Industrial, and Aerospace Engineering, Concordia University, Montreal, QC H3G 1M8, Canada;
| | - Ion Stiharu
- Department of Mechanical, Industrial, and Aerospace Engineering, Concordia University, Montreal, QC H3G 1M8, Canada;
| | - Theo G. M. van de Ven
- Department of Chemistry, McGill University, 801 Sherbrooke St. West, Montreal, QC H3A 0B8, Canada;
| | - Vahe Nerguizian
- Department of Electrical Engineering, École de Technologie Supérieure, 1100 Notre Dame West, Montreal, QC H3C 1K3, Canada;
| |
Collapse
|
2
|
Yilmazer A, Eroglu Z, Gurcan C, Gazzi A, Ekim O, Sundu B, Gokce C, Ceylan A, Giro L, Unal MA, Arı F, Ekicibil A, Ozgenç Çinar O, Ozturk BI, Besbinar O, Ensoy M, Cansaran-Duman D, Delogu LG, Metin O. Synergized photothermal therapy and magnetic field induced hyperthermia via bismuthene for lung cancer combinatorial treatment. Mater Today Bio 2023; 23:100825. [PMID: 37928252 PMCID: PMC10622883 DOI: 10.1016/j.mtbio.2023.100825] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Revised: 09/22/2023] [Accepted: 09/28/2023] [Indexed: 11/07/2023] Open
Abstract
Thanks to its intrinsic properties, two-dimensional (2D) bismuth (bismuthene) can serve as a multimodal nanotherapeutic agent for lung cancer acting through multiple mechanisms, including photothermal therapy (PTT), magnetic field-induced hyperthermia (MH), immunogenic cell death (ICD), and ferroptosis. To investigate this possibility, we synthesized bismuthene from the exfoliation of 3D layered bismuth, prepared through a facile method that we developed involving surfactant-assisted chemical reduction, with a specific focus on improving its magnetic properties. The bismuthene nanosheets showed high in vitro and in vivo anti-cancer activity after simultaneous light and magnetic field exposure in lung adenocarcinoma cells. Only when light and magnetic field are applied together, we can achieve the highest anti-cancer activity compared to the single treatment groups. We have further shown that ICD-dependent mechanisms were involved during this combinatorial treatment strategy. Beyond ICD, bismuthene-based PTT and MH also resulted in an increase in ferroptosis mechanisms both in vitro and in vivo, in addition to apoptotic pathways. Finally, hemolysis in human whole blood and a wide variety of assays in human peripheral blood mononuclear cells indicated that the bismuthene nanosheets were biocompatible and did not alter immune function. These results showed that bismuthene has the potential to serve as a biocompatible platform that can arm multiple therapeutic approaches against lung cancer.
Collapse
Affiliation(s)
- Açelya Yilmazer
- Department of Biomedical Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Türkiye
- Stem Cell Institute, Ankara University, 06520, Ankara, Türkiye
| | - Zafer Eroglu
- Department of Chemistry, Faculty of Science, Koç University, 34450, Istanbul, Türkiye
| | - Cansu Gurcan
- Department of Biomedical Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Türkiye
- Stem Cell Institute, Ankara University, 06520, Ankara, Türkiye
| | - Arianna Gazzi
- Department of Chemical and Pharmaceutical Sciences, University of Trieste, 34127, Trieste, Italy
- Department of Biomedical Sciences, University of Padua, 35129, Padua, Italy
| | - Okan Ekim
- Department of Anatomy, Faculty of Veterinary Medicine, Ankara University, 06110, Ankara, Türkiye
| | - Buse Sundu
- Department of Chemistry, Faculty of Science, Koç University, 34450, Istanbul, Türkiye
| | - Cemile Gokce
- Department of Biomedical Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Türkiye
| | - Ahmet Ceylan
- Department of Histology Embryology, Faculty of Veterinary Medicine, Ankara University, 06110, Ankara, Türkiye
| | - Linda Giro
- Department of Biomedical Sciences, University of Padua, 35129, Padua, Italy
| | | | - Fikret Arı
- Department of Electrical Electronic Engineering, Faculty of Engineering, 06830, Ankara, Türkiye
| | - Ahmet Ekicibil
- Department of Physics, Faculty of Arts and Sciences, Cukurova University, 01330, Adana, Türkiye
| | - Ozge Ozgenç Çinar
- Department of Histology Embryology, Faculty of Veterinary Medicine, Ankara University, 06110, Ankara, Türkiye
| | - Berfin Ilayda Ozturk
- Department of Biomedical Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Türkiye
| | - Omur Besbinar
- Department of Biomedical Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Türkiye
- Stem Cell Institute, Ankara University, 06520, Ankara, Türkiye
| | - Mine Ensoy
- Biotechnology Institute, Ankara University, 06135, Ankara, Türkiye
| | | | - Lucia Gemma Delogu
- Department of Biology, College of Arts and Sciences, Khalifa University, Abu Dhabi, UAE
- Department of Biomedical Sciences, University of Padua, 35129, Padua, Italy
| | - Onder Metin
- Department of Chemistry, Faculty of Science, Koç University, 34450, Istanbul, Türkiye
- Koç University Surface Science and Technology Center (KUYTAM), Istanbul, 34450, Türkiye
| |
Collapse
|
3
|
Bhatt HN, Pena-Zacarias J, Beaven E, Zahid MI, Ahmad SS, Diwan R, Nurunnabi M. Potential and Progress of 2D Materials in Photomedicine for Cancer Treatment. ACS APPLIED BIO MATERIALS 2023; 6:365-383. [PMID: 36753355 PMCID: PMC9975046 DOI: 10.1021/acsabm.2c00981] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
Over the last decades, photomedicine has made a significant impact and progress in treating superficial cancer. With tremendous efforts many of the technologies have entered clinical trials. Photothermal agents (PTAs) have been considered as emerging candidates for accelerating the outcome from photomedicine based cancer treatment. Besides various inorganic and organic candidates, 2D materials such as graphene, boron nitride, and molybdenum disulfide have shown significant potential for photothermal therapy (PTT). The properties such as high surface area to volume, biocompatibility, stability in physiological media, ease of synthesis and functionalization, and high photothermal conversion efficiency have made 2D nanomaterials wonderful candidates for PTT to treat cancer. The targeting or localized activation could be achieved when PTT is combined with chemotherapies, immunotherapies, or photodynamic therapy (PDT) to provide better outcomes with fewer side effects. Though significant development has been made in the field of phototherapeutic drugs, several challenges have restricted the use of PTT in clinical use and hence they have not yet been tested in large clinical trials. In this review, we attempted to discuss the progress, properties, applications, and challenges of 2D materials in the field of PTT and their application in photomedicine.
Collapse
Affiliation(s)
- Himanshu N. Bhatt
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, Texas 79902, United States; Department of Biomedical Engineering, The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Jaqueline Pena-Zacarias
- Department of Biological Sciences, The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Elfa Beaven
- Department of Biomedical Engineering, The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Md Ikhtiar Zahid
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, Texas 79902, United States; Environmental Science & Engineering, The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Sheikh Shafin Ahmad
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, Texas 79902, United States; Environmental Science & Engineering and Aerospace Center (cSETR), The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Rimpy Diwan
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, Texas 79902, United States; Department of Biomedical Engineering, The University of Texas El Paso, El Paso, Texas 79968, United States
| | - Md Nurunnabi
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, Texas 79902, United States; Department of Biomedical Engineering, Environmental Science & Engineering, and Aerospace Center (cSETR), The University of Texas El Paso, El Paso, Texas 79968, United States
| |
Collapse
|
4
|
Iravani S, Varma RS. MXenes in Cancer Nanotheranostics. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:nano12193360. [PMID: 36234487 PMCID: PMC9565327 DOI: 10.3390/nano12193360] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2022] [Revised: 09/22/2022] [Accepted: 09/23/2022] [Indexed: 05/21/2023]
Abstract
MXenes encompass attractive properties such as a large surface area, unique chemical structures, stability, elastic mechanical strength, excellent electrical conductivity, hydrophilicity, and ease of surface functionalization/modifications, which make them one of the broadly explored two-dimensional materials in the world. MXene-based micro- and nanocomposites/systems with special optical, mechanical, electronic, and excellent targeting/selectivity features have been explored for cancer nanotheranostics. These materials exhibit great diagnostic and therapeutic potential and offer opportunities for cancer photoacoustic imaging along with photodynamic and photothermal therapy. They can be applied to targeted anticancer drug delivery while being deployed for the imaging/diagnosis of tumors/cancers and malignancies. MXene-based systems functionalized with suitable biocompatible or bioactive agents have suitable cellular uptake features with transferring potential from vascular endothelial cells and specific localization, high stability, and auto-fluorescence benefits at different emission-excitation wavelengths, permitting post-transport examination and tracking. The surface engineering of MXenes can improve their biocompatibility, targeting, bioavailability, and biodegradability along with their optical, mechanical, and electrochemical features to develop multifunctional systems with cancer theranostic applications. However, challenges still persist in terms of their environmentally benign fabrication, up-scalability, functionality improvement, optimization conditions, surface functionalization, biocompatibility, biodegradability, clinical translational studies, and pharmacokinetics. This manuscript delineates the recent advancements, opportunities, and important challenges pertaining to the cancer nanotheranostic potential of MXenes and their derivatives.
Collapse
Affiliation(s)
- Siavash Iravani
- Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran
- Correspondence: (S.I.); (R.S.V.)
| | - Rajender S. Varma
- Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic
- Correspondence: (S.I.); (R.S.V.)
| |
Collapse
|